Prevalence of Opioid and Benzodiazepine Prescriptions for Osteoarthritis
- 25 May 2019
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 72 (8), 1081-1086
- https://doi.org/10.1002/acr.23933
Abstract
Background Opioids and benzodiazepines are commonly used for management of osteoarthritis despite evidence‐based recommendations to the contrary. This study aims to quantify the prevalence of opioid and benzodiazepine prescribing for osteoarthritis. Additionally, we aim to characterize risk factors for prescription drug misuse, abuse, and diversion among this population. Methods We conducted a descriptive analysis of adult outpatient encounters with a primary diagnosis of osteoarthritis during a one‐year period at a large healthcare system, excluding cancer and outpatient procedures. Demographic data, prescription data, and patient‐specific risk factors were collected. Descriptive analysis was conducted to characterize arthritis patients who received and did not receive prescription opioids. Results During one year, our system had 31,123 outpatient encounters for osteoarthritis. Opioids and benzodiazepines were prescribed for nearly 27% of the encounters (n=8,420). 43% of the encounters involved patients >65 years old. Hydrocodone‐acetaminophen was the most common medication prescribed (34.3%). Most prescriptions were written by pain specialists (53%). 35.5% had a risk factor for prescription misuse, the most prevalent being “early refill” and a history of receiving 3 or more prescriptions in the past month. Conclusions Opioids and benzodiazepines continue to be written for osteoarthritis. These prescriptions may pose a risk for adverse outcomes since greater than one in 5 patients receiving prescriptions had a risk factor for misuse. Continued efforts to improve compliance with evidence‐based guidelines as well as multimodal and alternative pain management pathways are critical to help curb the use of opioids for management of osteoarthritis‐related pain.Funding Information
- National Center for Injury Prevention and Control (CE14‐004 Award Number CE002520)
This publication has 35 references indexed in Scilit:
- The Opioid EpidemicJournal of the American Academy of Orthopaedic Surgeons, 2015
- BenzodiazepinesJournal of Pharmacy Practice, 2014
- Towards a mechanism-based approach to pain management in osteoarthritisNature Reviews Rheumatology, 2013
- AAOS Clinical Practice Guideline: Treatment of Osteoarthritis of the Knee: Evidence-Based Guideline, 2nd EditionJournal of the American Academy of Orthopaedic Surgeons, 2013
- Side Effects From Oral Opioids in Older Adults During the First Week of Treatment for Acute Musculoskeletal PainAcademic Emergency Medicine, 2013
- Newly Initiated Opioid Treatment and the Risk of Fall-Related InjuriesCNS Drugs, 2013
- Prescribing opioids in older peopleMaturitas, 2012
- Medication-Related Falls in the ElderlyDrugs & Aging, 2012
- The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic reviewOsteoarthritis and Cartilage, 2011
- Comparison of Opioid Requirements and Analgesic Response in Opioid‐Tolerant versus Opioid‐Naïve Patients After Total Knee ArthroplastyPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2008